InvestorsHub Logo
Followers 0
Posts 14
Boards Moderated 0
Alias Born 08/31/2017

Re: None

Friday, 01/12/2018 10:09:48 AM

Friday, January 12, 2018 10:09:48 AM

Post# of 6389
I have been following this board for some time and appreciate all of the informative posts. I have been a shareholder of Biopath since 2008. I recently came across information about Opgen, a company that is also hoping to avoid delisting with a reverse stock split proposal at their shareholder meeting next week.

They are also incorporated in Delaware. They submitted a Q&A with their shareholder meeting proposals. They specifically discuss what their definition of a "broker non-vote" is. They deem a Reverse Stock Split as a "non-routine" proposal, and indicate that broker non votes would count against such a proposal. As a non-routine proposal, brokers would not have discretionary authority to vote on this proposal if they had not received instructions from the stock owner.

Here is a link to the Opgen shareholder material: https://seekingalpha.com/filing/3801775
See page 3 of their Q & A section.

If an attorney agrees with this opinion, I would be happy to contribute to our cause.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BPTH News